Alcon Medical Device Company Intelligence Report

Date: January 30, 2013
Pages: 23
US$ 515.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)

Download PDF Leaflet

Alcon Medical Device Company Intelligence Report
Incorporated in 1947, Alcon is headquartered in Hunenberg, Switzerland, where it develops, manufactures and markets eye care products in over 180 countries. In April 2011, Alcon was merged into Novartis. As a result, Alcon became Novartis’ ophthalmic division and CIBA Vision became part of Alcon.

Alcon’s eyecare products include ophthalmic surgical equipment and devices designed for cataract, vitreoretinal, refractive and glaucoma surgery; pharmaceutical products for the treatment of glaucoma, eye infections, inflammation and allergies; and consumer vision care products, which include artificial tears, contact lens care solutions, ocular nutrition and now Novartis’ CIBA Vision. Alcon’s generic division, Falcon, was merged in Novartis’ generic business unit, Sandoz, as a result of the April 2011 acquisition. This report focuses on the company's surgical products business.

Alcon's main competitors in the ophthalmic surgical market include Abbott Medical Optics (AMO, formerly Advanced Medical Optics) and Bausch & Lomb. In the contact lens care product market, Alcon's principal competitors are Allergan, Johnson & Johnson's Vistakon, AMO, Bausch & Lomb and, in Japan, Rohto Pharmaceutical Company. Other competitors include Merck & Co, Lumenis, Cooper Companies, Carl Zeiss Meditec and Santen Pharmaceutical Company.

Collectively, Alcon and Novartis claim more than 70 per cent of the worldwide vision care sector. Novartis also has long-standing activities in contact lenses, a sector in which Alcon is not active, and a complementary ophthalmic pharmaceuticals portfolio.

Since Novartis’ acquisition of Alcon, total revenues have increased significantly, totalling US$9,958 million for the year ended 31st December 2011, an increase of 38.7 per cent over the previous year. The addition of the CIBA Vision business unit to Alcon’s consumer eyecare unit and some of Novartis’ eyecare pharmaceuticals to Alcon’s product portfolio has boosted revenue. Strong growth in pharmaceuticals and surgical products contributed to the large increase.

According to Novartis Alcon’s growth in the US has slowed, while emerging markets are posting strong growth for the company. Sales in Novartis’ top six emerging markets grew by 26 per cent in 2011, on a pro forma basis, led by growth in China and India.

Cataract products were Alcon’s top-selling Surgical segment. Cataract intraocular lenses showed strong growth in the emerging markets and slower growth in the US. Sales of advanced technology intra-ocular lenses (IOLs) rose by around 16 per cent on a pro forma basis, mainly due to strong sales of AcrySof IQ Toric and AcrySof IQ ReSTOR +3.0. Sales of the Constellation vitreoretinal surgical system contributed to the sales growth within the Vitreoretinal segment.

The integration into Novartis has improved Alcon’s performance significantly. With a number of acquisitions by Alcon, new product launches throughout 2011 and 2012 and a robust pipeline, Alcon’s prospects in the medium- to long-term look promising.

This company report provides

  • Key contact information
  • Introduction to the company and its current activities
  • Summary of its financial performance
  • Who are the company’s major competitors?
  • Key recent events in an “at a glance” format
Financial Review
  • Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
  • Table providing in-depth five-year financial analysis
  • Employee data, including breakdown by company division and geographic location
Strategic Focus

Investigates the company’s aims and its areas of focus


Core product areas, key brands, product approvals and launches

Research and Development
  • How much has been invested in R&D?
  • Where is the research based?
  • What alliances and agreements does the company have and with whom?
Manufacturing and Distribution
  • Identifying the company’s manufacturing locations
  • Sales and marketing facilities
  • With whom has the company reached agreements and what do they involve?
  • Key contracts awarded
Mergers, Acquisitions, Minority Investments and Divestments


Key Corporate Events


Cataract Surgery
Vitreoretinal Surgery
Refractive Surgery
Espicom View


Financial Results, 2011
Five-Year Financial Data


Cataract Surgery Products
  LenSx laser
  Infiniti Vision System
  Centurion Vision System
AcrySof Intraocular Lenses
  AcrySof Natural
  AcrySof IQ
  AcrySof ReSTOR/AcrySof ReSTOR Aspheric
  AcrySof Toric
Laureate System
Viscoelastic Devices
  ProVisc Ophthalmic Viscosurgical Device
  DisCoVisc Ophthalmic Viscosurgical Device
  DuoVisc Viscoelastic System
Refractive Surgery Products
  Allegretto Wave Eye-Q Excimer Laser System
  LADARVision System
  LADAR6000 Excimer Laser
  WaveLight Fs200 Laser
Vitreoretinal Surgery Products
  Accurus Surgical System
  Constellation Surgical System
  PurePoint Laser System
  Grieshaber Microsurgical Instruments
  Perfluoro-n Liquid
  Silikon 1000 Ophthalmic Surgical Oil
  Triescence Suspension
Glaucoma Surgery Products
  Ex-Press Glaucoma Filtration Device
General Surgical Products
  BSS Plus
  Custom Paks
  Other Disposable Products




Advanced Medical Optics (now Abbott Medical Optics)
Supply Agreements


Acquisition by Novartis
Sensomotoric Instruments Ophthalmic Division
Endure Medical Systems
LenSx Lasers
WaveLight AG


Alcon Cusί SA


Generic Drug Patent Infringement Actions
Synergetics USA



Recent Key Events
Alcon – Consolidated Annual Financial Results, 2007-2011
Alcon – Consolidated Annual Revenues by Segment, 2007-2011
Alcon – Annual Surgical Revenues by Product Type, 2010-2011
Alcon - Five-Year Financial Summary, 2007-2011
Alcon - Recent Surgical Product Approvals
Alcon Surgical Products Under Development, 2011
Alcon Surgical Manufacturing Facilities, 2011
Mergers and Acquisitions Summary


Alcon - Annual Revenues and Operating Income, 2007-2011
Alcon - Annual Revenues by Business Segment, 2007-2011
Alcon - Annual Surgical Revenues by Product Type, 2010-2011
Alcon - Sales by Product Area, 2011
Skip to top

Ask Your Question

Alcon Medical Device Company Intelligence Report
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: